← Open Payments lookup

AMANDA HARMON: Open Payments

NPI 1093407041 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$588 in 32 payments from 12 companies in 2025. Trend: 2023 $302 · 2024 $525 · 2025 $588

Food & beverage: $588
CompanyPaymentsAmount
Astellas Pharma US Inc4$113
MILLICENT US INC4$80
Bayer Healthcare Pharmaceuticals Inc.5$77
MAYNE PHARMA COMMERCIAL LLC7$63
Biogen, Inc.2$57
Exeltis, USA Inc.3$49
ABBVIE INC.2$36
Kerecis Limited1$28
CooperSurgical, Inc.1$27
Octapharma USA, Inc.1$22

Products named: Veozah, ZURZUVAE, SLYND, Mirena, FEMLYV, INTRAROSA, LILETTA, Kerecis SurgiClose.

Industry payments across IN — which companies pay providers there.